Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators

Irritable Bowel Syndrome

(2017) Alexander C. Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917

(2017) Teresa Pérez-Berezo et al.   Nature Communications

Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome

(2017) Aldona Dlugosz et al.   Biomed Research International

Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism

(2016) Maria Raffaella Barbaro et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Efficacy of Prebiotics, Probiotics and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

(2014) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Escherichia coliNissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage

(2014) Hanru Wang et al.   CANCER BIOLOGY & THERAPY

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome

(2014) Y. Nasser et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis

(2014) M. Bashashati et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Myosin light chain kinase: pulling the strings of epithelial tight junction function

(2012) Kevin E. Cunningham et al.   Annals of the New York Academy of Sciences

Intestinal microbiota in functional bowel disorders: a Rome foundation report

(2012) Magnus Simrén et al.   GUT

Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

(2012) Patrick A Hughes et al.   GUT

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier

(2012) Cristina Martínez et al.   GUT

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Probiotic metabolites as epigenetic targets in the prevention of colon cancer

(2012) Manoj Kumar et al.   NUTRITION REVIEWS

Influence of leucine on protein metabolism, phosphokinase expression, and cell proliferation in human duodenum

(2011) Moïse Coëffier et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells

(2011) M Vivinus-Nébot et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal Serotonin Release, Sensory Neuron Activation and Abdominal Pain in Irritable Bowel Syndrome

(2011) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

(2011) Wolfgang Kruis et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome

(2010) Elizabeth K Brint et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Stimulating Expression of Toll-Like Receptor 5, CD14, MyD88, and TRIF Together with the Induction of Interleukin-8 Expression via the Mitogen-Activated Protein Kinase Pathway in Epithelial Cells

(2010) M. Hafez et al.   INFECTION AND IMMUNITY

Microbiota restoration: natural and supplemented recovery of human microbial communities

(2010) Gregor Reid et al.   NATURE REVIEWS MICROBIOLOGY

Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms

(2009) Cesare Cremon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

T-Cell Activation in Patients With Irritable Bowel Syndrome

(2009) Lena Öhman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome

(2009) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis

(2009) Rudolf Mennigen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress

(2009) Luke A. J. O'Neill   IMMUNOLOGICAL REVIEWS

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

(2009) QiQi Zhou et al.   PAIN

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

(2008) T Piche et al.   GUT

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

(2008) P. Moayyedi et al.   GUT

Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity

(2008) K. Gecse et al.   GUT

Lactobacillus casei downregulates commensalsʼ inflammatory signals in Crohnʼs disease mucosa

(2008) Marta Llopis et al.   INFLAMMATORY BOWEL DISEASES

Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients

(2008) a. m. schoepfer et al.   NEUROGASTROENTEROLOGY AND MOTILITY